CIK 0001598646 · Non-accelerated filer<br>Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 260784194
- Phone
- 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +2,328 | 2,328 | ||
| 2026-08-03 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +12,147 | 12,147 | ||
| 2026-06-03 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +1,690,700 | 1,690,700 | ||
| 2026-06-03 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +680,000 | 680,000 | ||
| 2026-06-03 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-04-21 | O'Connor James Joseph Chief Business Officer and GC | Grant or award · Employee Stock Option (right to buy) | +350,800 | 350,800 | ||
| 2026-03-31 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +12,169 | 12,169 | ||
| 2025-12-22 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +364,504 | 364,504 | ||
| 2025-12-22 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-12-22 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-12-22 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +2,250,000 | 2,250,000 | ||
| 2025-12-22 | Race Geoff President | Grant or award · Employee Stock Option (right to buy) | +1,500,000 | 1,500,000 | ||
| 2025-12-22 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2025-12-22 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-12-22 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-11-14 | Kaul Inderjit Director | Grant or award · Stock Option (right to buy) | +9,500 | 9,500 |
Page 1 of 6 · 120 trades